The rejection rate of volunteers who wanted to participate in Phase 2 clinical trials of the Patria Vaccine was 3 out of 4, reported the head of the National Council of Science and Technology (Conacyt), María Elena Álvarez-Buylla Roces.
At a press conference for the collaboration agreement between Conacyt and the Mexican Social Security Institute (IMSS), held this Tuesday, April 19, Álvarez-Buylla said that the rejection was due to the fact that volunteers did not reach the required antibody levels, which were less than 1,200.
Before the Ómicron variant, the rejection rate was 1 in 2, but as vaccination progressed, rejection levels rose considerably, as it was more difficult to find people with this level of antibodies when they had already received a dose of the COVID-19 vaccine.
Likewise, the head of Conacyt indicated that she expects the R2 clinical trial to be completed within a few months, without giving a specific date, but she assured that the estimated time for the conclusion of this phase would be less than a year.
Once the R2 clinical trials (phase two of reinforcement) have been completed, the R3 trials will be carried out, which will allow a higher recruitment rate than the current one, explained Álvarez-Buylla, so progress would be made more quickly and effectively.
It should be noted that the World Health Organization (WHO) warned that the Patria vaccine could obtain its emergency use record as long as it had a validated file that guarantees its safety and efficiency. However, for this, phases 2 and 3 must be completed.
In view of this, the head of the Undersecretariat for Health Prevention and Promotion, Hugo López-Gatell, has extended the invitation to citizens to participate in the clinical trials of the Phase 2 that are currently being carried out. Likewise, at a morning conference on April 5, he commented that he sees the advance of the vaccine as very “promising”.
Phase 2 requires more than 400 volunteers who must meet the following requirements: live in CDMX; be over 18 years old; have received a complete vaccination schedule (regardless of the vaccine) 4 months before; have not had respiratory diseases within the last 21 days; not be pregnant and not participate in another study protocol.
The project is in charge of the Government of Mexico and Laboratorios Avimex. If you want to voluntarily join the phase 2 clinical trials, the following page has been enabled for registration: https://encuestas.conacyt.mx/index.php/831584. Upon completion of the 30-question questionnaire, the candidate will be notified if they are eligible to participate in these studies.
At the close of Sunday, April 17, the Ministry of Health reported that a total of 195 million 528 thousand 994 doses of vaccines against COVID have been supplied -19 since last December 24, 2020. In addition, 85 million 708 thousand 849 people have been immunized with at least one dose, of which 79 million 945 thousand 2 have the complete schedule.
KEEP READING:
Últimas Noticias
Debanhi Escobar: they secured the motel where she was found lifeless in a cistern
Members of the Specialized Prosecutor's Office in Nuevo León secured the Nueva Castilla Motel as part of the investigations into the case
The oldest person in the world died at the age of 119
Kane Tanaka lived in Japan. She was born six months earlier than George Orwell, the same year that the Wright brothers first flew, and Marie Curie became the first woman to win a Nobel Prize
Macabre find in CDMX: they left a body bagged and tied in a taxi
The body was left in the back seats of the car. It was covered with black bags and tied with industrial tape
The eagles of America will face Manchester City in a duel of legends. Here are the details
The top Mexican football champion will play a match with Pep Guardiola's squad in the Lone Star Cup
Why is it good to bring dogs out to know the world when they are puppies
A so-called protection against the spread of diseases threatens the integral development of dogs
